Skip to main content

Closed

ADCT: ADC Therapeutics S.A. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-148.8%

ROIC-51.6%

Financially safe

Stretched

Debt / equity-0.54×

Interest coverage-2.3×

Current ratio4.09×

ADC Therapeutics S.A.

ADCTNew York Stock Exchange·USD·Closed

ADC Therapeutics S.A.

ADCTNew York Stock Exchange·USD·Closed

$1.05

−5.41%

$1.05

−$0.06 (5.41%)

52W Range

6thpctl

Volume

0.33×avg

Mkt Cap

133.55MUSD

P/E

-1.2TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.33×avg

Market Cap

133.55MUSD

P/E Ratio

-1.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings